Omeros
Omeros discovers, develops and commercializes small-molecule and protein therapeutics for inflammation and disorders of central nervous system.
Business Model:
Revenue: $97.7M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Omeros Information
Geographic Data
Address: 201 Elliott Avenue West
City: Seattle
State: WA
Zip: 98119
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$100M
Raised Total:$88M
Social
Metrics
2,400,134Website Global Rank
7,595Website Monthly Traffic
Twitter Followers
Description
Omeros discovers, develops and commercializes small-molecule and protein therapeutics for inflammation and disorders of central nervous system.
Contact Phone:
+12066765000
Contact Email:
Omeros went public on 10/8/2009 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/8/2009
IPO Valuation:
$84M
Ticker Symbol:
OMER
IPO Price:
$20.03/share
Amount Raised:
$84M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 9/2006 | Nura |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
